Food and Drug Administration

Oncologic Drugs Advisory Committee

December 6, 2001


Therapy of Colorectal Cancer with Combination Regimens of CAMPTOSAR® (Irinotecan, CPT-11), 5-Fluorouracil (5-FU), and Leucovorin (LV), Pharmacia   pdf

A Post-Marketing Evaluation of Safety, Isagani M Chico, MD, Medical Officer   ppt   htm

Gliadel® Wafter sNDA 20-637s, Guilford Pharmaceuticals Inc.  ppt   htm

sNDA #20-637 Gliadel® Wafter (Polifeprosan 20 with Carmustine Implant), Medical Reviewer:  Alla Shapiro MD PhD, Statistical Reviewer:  Ning Li, MD PhD   ppt   htm